Recall: Hospira Lidocaine Injection

The FDA has announced a recall of one lot of Hospira Lidocaine HCl Injection, USP, 2%, 5 mL Single-Dose Vial (NDC 0409-2066-05), Lot 32-135-DD, expiration date 1AUG2015 because of a potentially dangerous reddish orange particulate on the inner surface and floating in the solution.  For details see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm379751.htm.

Post QIP PSC before January 2

On December 13, 2013 the Final PY 2014 Performance Score Report (PSR) and QIP Performance Score Certificate (PSC) for 2014 became available for download on http://www.dialysisreports.org.  The PSR and PSC should be accessed within 5 business days of the CMS release date – this week, in other words.

Facilities are required to display both the English and Spanish versions of their 2014 QIP Performance Score Certificate (PSC) no later than January 1, 2014 in a conspicuous place where other patient-directed materials are posted so that they are in plain view and easily visible for all patients and their parents/guardians or representatives to inspect.  The certificates must be posted for the entire year, January 1 – December 31, 2014)   All 4 pages of the PSC must be posted.

HIV Organ Policy Equity Act

The American Association of Kidney Patients reports that the HIV Organ Policy Equity (HOPE) Act, which allows for the study of HIV-positive organs to be donated to those in need who are also HIV positive, is now the law of the land.  Before the HOPE Act, it was illegal even to study HIV-positive organ transplants.  Now researchers can investigate whether or not it is safe for HIV-positive patients to receive an organ from another HIV-positive patient.  Expect UNOS to ask for policy input soon.  For more information see http://www.transplantliving.org/community/newsroom/2013/11/unos-applauds-congressional-passage-of-hope-act/.